From: Clinical evaluation of pregnant women with SARS-COV2 pneumonia: a real-life study from Egypt
Variable | Pregnant COVID-19 (n = 64) | Non-pregnant COVID-19 (n = 114) | P value |
---|---|---|---|
Age (in years) | 34.93 ± 6.27 | 36.91 ± 8.60 | 0.109 |
Trimester | |||
 First | 9 (14.1) | – | – |
 Second | 16 (25.0) |  |  |
 Third | 39 (60.9) |  |  |
Co-morbidities | |||
 No | 53 (82.8) | 88 (77.2) | 0.700 |
 HTN | 4 (6.25) | 11 (9.6) |  |
 DM | 3 (4.7) | 9 (7.9) |  |
 Others | 4 (6.25) | 6 (5.3) |  |
O2 saturation | |||
100–95% | 50 (78.1) | 74 (64.9) | 0.206 |
 95–90% | 6 (9.4) | 23 (20.2) |  |
 90–85% | 5 (7.8) | 8 (7.0) |  |
 < 85% | 3 (4.7) | 9 (7.9) |  |
Disease severity | |||
 Mild | 44 (68.8) | 75 (65.8) |  |
 Moderate | 16 (25.0) | 36 (31.6) | 0.363 |
 Severe | 4 (6.2) | 3 (2.6) |  |